Navigation Links
InterMune Reports Preliminary Fourth Quarter 2011 Esbriet® (pirfenidone) Revenue and Other Recent Business Highlights
Date:1/5/2012

therapies for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease.  Pirfenidone, the only medicine approved worldwide for IPF, is approved for marketing by InterMune in the EU as Esbriet® and is currently in a Phase 3 clinical trial in the United States.  Pirfenidone is also approved for the treatment of IPF in Japan, where it is marketed by Shionogi & Co. Ltd. under the trade name Pirespa®.  InterMune's research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases.  For additional information about InterMune and its R&D pipeline, please visit www.intermune.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934, as amended, that reflect InterMune's judgment and involve risks and uncertainties as of the date of this release, including without limitation the statements related to our expectations for Esbriet as an important therapy in the treatment of patients with IPF, our anticipated timing of commercial launches for Esbriet® (pirfenidone) in France, Italy, Spain,  the United Kingdom and other EU countries, our expectations regarding headcount in our EU commercial organization, our expectation regarding the timing of full enrollment in the ASCEND study and the prospects of success thereof, and our projections for operating expenses in each of 2011 and 2012. All forward-looking statements and other information included in this press release are based on information available to InterMune as of the date hereof, and InterMune assumes no obligation to update any such forward-looking statements or information. InterMune's actual results could differ materially from those described in InterMune's forward-loo
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. InterMune Appoints Angus C. Russell to Board of Directors
2. InterMune to Release Third Quarter Financial Results on November 3
3. InterMune Announces Launch of Esbriet® (pirfenidone) in Germany
4. InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study
5. InterMune Receives European Union Approval for Esbriet® (pirfenidone)
6. InterMune Reports Fourth Quarter and Full Year 2010 Financial Results and Business Highlights
7. InterMune to Present at J.P. Morgan Healthcare Conference
8. InterMune Reports Third Quarter 2010 Financial Results
9. InterMune Announces Four Oral Presentations on Pirfenidone and IPF at the Annual Congress of the European Respiratory Society (ERS)
10. InterMune to Release Second Quarter Financial Results on July 27
11. InterMune Announces Conference Call and Webcast to Discuss Outcome of FDA Advisory Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 Dynatronics Corporation (NASDAQ: ... has been appointed to the Company,s Board of Directors effective ... death in November 2014 of board member Joseph Barton ... to our Board of Directors represents an important step ... chairman and president of Dynatronics.  "Rich is a proven leader ...
(Date:3/27/2015)... March 27, 2015  Holographic Optical Technologies of ... of holographic medical imaging, is entering the world of ... Launching on April 20 th , 2015, the campaign ... The 8-inch and 22-inch displays will allow consumers to ... first time. In addition to the two displays, the ...
(Date:3/27/2015)... March 27, 2015  Victoria Vein & Surgery Clinic is ... Astanza Duality laser in Victoria, Texas . ... well as advanced laser treatments for a variety of medical ... industry to provide more services for their patients. Since adding ... Victoria residents get rid of their ...
Breaking Medicine Technology:Dynatronics Announces Appointment of Richard J. Linder to Board of Directors 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3Victoria Vein And Surgery Clinic Uses Advanced Astanza Duality Tattoo Removal Technology 2
... , WILMINGTON, Del. Oct. 27 If you,re one of ... for high blood pressure, here are some basics about this ... medicines also known as beta-adrenergic blocking agents. When you take ... force, reducing blood pressure. For these medicines to ...
... Lengthier cancer trials and new regulations have forced pharmaceutical ... increase efficiency. As a result, the use of medical ... has come to the forefront. Since imaging is a ... be conducted in a standardized fashion to optimize imaging data. ...
Cached Medicine Technology:Four Basics and Some Good Information About Beta-Blocker Treatment for High Blood Pressure 2Four Basics and Some Good Information About Beta-Blocker Treatment for High Blood Pressure 3RadMD Offers Tips on Optimizing Clinical Trial Efficiency 2RadMD Offers Tips on Optimizing Clinical Trial Efficiency 3
(Date:3/28/2015)... Take a bite of warm, gooey pepperoni pizza, ... into the stomach, ready to break down your meal. ... acids run amok, triggering a burning sensation in the ... 60 million Americans have heartburn at least once a ... how it can be stopped. , Heartburn or acid ...
(Date:3/28/2015)... Emergency Medical Care (EMC), a New York ... commemorated its three-year anniversary of being the only 24/7 ... 24-hour urgent care, Emergency Medical Care offers its clients ... Emergency Medical Care’s Urgent Care NYC services ... injuries, ear infections, fevers, insect bites, burns, animal bites, ...
(Date:3/28/2015)... 2015 Pitching speed, player’s height, and pitching ... and elbow injuries, according to new research released today at ... Specialty Day. , “Our findings indicate that a 10 inch ... likelihood of a history of injury, a 10 mile per ... likelihood of a history of injury, and playing for more ...
(Date:3/28/2015)... Early surgery may not be the best ... injuries, according to new research from Tripler Army Medical ... Society for Sports Medicine’s ( AOSSM ) Specialty Day, ... was not performed. , The final study group focused ... 17 receiving non-surgical therapy. Of the non-surgery group, 8 ...
(Date:3/28/2015)... March 28, 2015 Aureus Medical ... staffing, including physical therapy jobs, has announced that ... Ohio Physical Therapy Association Annual Conference to be ... Downtown Hotel in Columbus, OH. , The ... and exhibits with products and services. , ...
Breaking Medicine News(10 mins):Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2
... obesity boosts blood vessel function even without weight loss, ... Components of metabolic syndrome that appear in children should ... to improve their diet and exercise routines, a new ... they have at least three risk factors from among ...
... new study suggests that patients with hepatitis C (HCV) ... organ with high levels of fatty deposits (a.k.a. hepatic ... those transplanted with such livers. These findings are in ... journal published by John Wiley & Sons. The article ...
... care policyWASHINGTON, Jan. 13 The RAND Corporation ... and interested parties with a unique way of ... of health care reform proposals certain to be ... COMPARE (Comprehensive Assessment of Reform Efforts) is a ...
... Solutions Provider Integrates Award-Winning Fingerprint Recognition SolutionATLANTA, ... fingerprint biometrics research and development firm, announced ... of effective and high quality technology and ... M2SYS, Bio-Plugin(TM) Appserver fingerprint software into its ...
... Renz has been promoted to President & COO of HireAbility.com, the ... Executive Vice President of Operations and Technology for the past five ... training, and technologies. , ... Londonderry, NH (PRWEB) January ...
... provides a novel theory for how delusions arise and ... Devinsky, MD, performed an in-depth analysis of patients with ... of injury to the frontal lobe and right hemisphere ... these injuries to the right hemisphere, leads to the ...
Cached Medicine News:Health News:Diet, Exercise Cuts Kids' Risk for Metabolic Syndrome 2Health News:Transplanted fatty livers associated with worse prognosis for patients with HCV 2Health News:RAND Launches Unique Tool to Evaluate Health Care Proposals 2Health News:RAND Launches Unique Tool to Evaluate Health Care Proposals 3Health News:RAND Launches Unique Tool to Evaluate Health Care Proposals 4Health News:RPGSi Selects M2SYS Fingerprint Biometrics Software for Revolutionary Patient Identification System 2Health News:Amy Renz Promoted to President & COO of HireAbility.com, LLC 2Health News:Amy Renz Promoted to President & COO of HireAbility.com, LLC 3Health News:Delusions associated with consistent pattern of brain injury 2Health News:Delusions associated with consistent pattern of brain injury 3
... Wolf offers protection ... exceptional shielding values with ... high optical quality. Lenses ... equivalency and are anti-reflection ...
... protection in three formats, ... with lightweight comfort and ... Lenses provide .75 mm ... anti-reflection coated and tempered ...
... Special Protective Apron is made to ... a sterile gown. Uniquely it can ... field. Reaching through the back of ... released, and the protective apron will ...
... frontal protection, our conventional aprons ... by sturdy 2 webbed straps ... snap hook fasteners. The straps ... fit the apron. Our conventional ...
Medicine Products: